Shares of Longeveron Inc. blasted 120.9% higher connected precise progressive greeting trading Thursday, aft the biotechnology institution said its Lomecel-B for the attraction of a congenital bosom defect successful infants (Hypoplastic Left Heart Syndrome) affecting astir 1,000 babies a twelvemonth was granted uncommon pediatric illness (RPD) designation by the Food and Drug Administration. Trading measurement exploded to 112.0 cardinal shares, compared with the full-day mean of astir 110,000 shares. The banal was some the biggest gainer and astir progressive connected large U.S. exchanges. The institution said Lomecel-B is presently being evaluated successful a Phase 2 trial. Despite...
Published: Nov. 18, 2021 astatine 10:57 a.m. ET
English (US) ·